NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/15/2025
Back to search
Official data from USPTO
BIOSERA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
01/15/2025
Trademark type
Word
Nice classes
5
Filing date
03/14/2018
Registration date
01/08/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/15/2025
Last transaction
01/15/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
12/21/2004
First use in commerce
12/21/2004
Drawing code
4
Owner type
16
Owner location
Bradenton, FL, US
Examiner
MORENO, PAUL
Current location
Historical data usage
Holders and representatives
Holders
Biowest, L.L.C.
Biowest, L.L.C.
Representatives
Cheryl L. Burbach HOVEY WILLIAMS LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
veterinary and pharmaceutical preparationsserumsculture productsculture media for medical useaugmentationdifferentiationpreservationcultivation of bonetissuecellsmicroorganism cells for medical purposes; culture media for veterinary useaugmentationdifferentiationpreservationcultivation of bonetissuecellsmicroorganism cells for veterinary purposesantitoxic seravaccinesblood culture media for medical and veterinary usefor augmentationdifferentiationpreservationcultivation of bonetissuecellsmicroorganism cellsfor use in production of active ingredients of pharmaceuticalsprotein arrays for medical use in binding and detecting antibodiesantitoxic sera for medical purposesuse in vaccinescell and tissue cultures and in growth media supplements; reagents for medical use; chemical reagents for medical or veterinary purposessaline wash for medical purposessaline solution for medical purposes; bacteriological culture mediumscultures of microorganisms for medical or veterinary use; veterinary and pharmaceutical preparations for the treatment of infectious diseases; animal sera for bacteriological cultures; biological preparations for medical research; antibiotics; medical diagnostic bufferssaltssolutions and reagents for use in disease testing
Publications
History of USPTO decisions and trademark events.
21 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/15/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/15/2025
E815
TEAS SECTION 8 & 15 RECEIVED
08/21/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/08/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/08/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/23/2018
PUBO
PUBLISHED FOR OPPOSITION
10/23/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/03/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/19/2018
ALIE
ASSIGNED TO LIE
09/17/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/16/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/16/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/16/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/05/2018
GNRT
NON-FINAL ACTION E-MAILED
07/05/2018
CNRT
NON-FINAL ACTION WRITTEN
07/05/2018
DOCK
ASSIGNED TO EXAMINER
06/25/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/27/2018
NWAP
NEW APPLICATION ENTERED
03/17/2018
Continuous trademark protection
Get notified about every new filing that threatens BIOSERA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.